IP Library Granted Patent US 8,846,767
Granted Patent B2
US 8,846,767 · App. 11/400,839 · Granted Sep 30, 2014

Flow path conditioner system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,846,767
App. No.
11/400,839
Granted
Sep 30, 2014
Kind
B2
Abstract

Compositions ( 3 ) and methods of using such compositions ( 3 ) to condition, clean, or disinfect the flow path of a conduit ( 8 ) of a microfluidic devices ( 16 ), such as flow cytometers or liquid chromatographs.

Claims (14)

1. A method of reducing a number of viable microorganisms in a flow path of a microfluidic device, comprising:

a) mixing an antimicrobially active agent including diacetone alcohol between about 10% and about 70% by volume and an inactive agent comprising water between about 30% and about 90% to produce an aqueous miscible antimicrobial composition, wherein said diacetone alcohol is the only antimicrobially active agent effective for reducing said number of viable microorganisms in said microfluidic device by contact with said aqueous miscible antimicrobial composition;

b) flowing an amount of said aqueous miscible antimicrobial composition within said flow path of said microfluidic device;

c) contacting said number of viable microorganisms in said flow path of said microfluidic device with said aqueous miscible antimicrobial composition; and

d) reducing said number of viable microorganisms in said flow path of said microfluidic device by contact of said aqueous miscible antimicrobial composition with said viable microorganisms.

2. The method of reducing a number of viable microorganisms in a flow path of a microfluidic device of claim 1 , wherein said antimicrobially active agent consists essentially of said amount of diacetone alcohol between about 30% and about 50% by volume and said inactive agent comprising said amount of water between about 50% and about 70% by volume.

3. The method of reducing a number of viable microorganisms in a flow path of a microfluidic device of claim 2 , further comprising the steps of:

a) flowing a first fluid within said flow path of said microfluidic device prior to flowing said amount of said aqueous miscible antimicrobial composition within said flow path of said microfluidic device;

b) flowing an amount of said aqueous miscible antimicrobial composition in said flow path of said microfluidic device for a first duration of time sufficient to displace said first fluid in said flow path of said microfluidic device; and

c) flowing said aqueous miscible antimicrobial composition in said flow path of said microfluidic device for a second duration of time of between about thirty seconds and about ten minutes.

4. The method of reducing a number of viable microorganisms in a flow path of a microfluidic device of claim 3 , further comprising the step of displacing said amount of aqueous miscible antimicrobial composition in said flow path of said microfluidic device by flowing an amount of said first fluid in said flow path of said microfluidic device for a duration of time of between about thirty seconds and about fifteen minutes.

5. The method of reducing a number of viable microorganisms in a flow path of a microfluidic device of claim 1 or 4 , wherein said microfluidic device comprises a flow cytometer.

6. The method of reducing a number of viable microorganisms in a flow path of a microfluidic device of claims 5 , further comprising the step of locating said amount of aqueous miscible antimicrobial composition in a variable volume container having a flexible wall which provides an external surface on which an amount of gas exerts an amount of pressure sufficient to generate a flow of said composition in said flow path of said flow cytometer.

7. The method of reducing a number of viable microorganisms in a flow path of a microfluidic device of claim 6 , wherein said antimicrobially active agent consists essentially of said amount of diacetone alcohol of about 40% by volume and said inactive agent comprising said amount of water of about 60% by volume.

Assignments (5)
SECURITY INTEREST Recorded Nov 24, 2025
From: XY, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073020/0041 →
SECURITY INTEREST Recorded Mar 31, 2021
From: XY, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0548 →
SECURITY INTEREST Recorded Mar 18, 2021
From: BBVA USA, FORMERLY KNOWN AS COMPASS BANK
To: XY, LLC
Reel/Frame 055653/0800 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY'S NAME PREVIOUSLY RECORDED AT REEL: 027039 FRAME: 0699. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 23, 2014
From: CHATA BIOSYSTEMS, INC.
To: CHD BIOSCIENCE, INC.
Reel/Frame 033794/0389 →
SECURITY AGREEMENT Recorded Sep 7, 2012
From: XY, LLC
To: COMPASS BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 028912/0283 →